The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study

BACKGROUND: Thymosin α1 therapy was commonly used in patients with coronavirus disease 2019 (COVID-19), while its impact on outcomes and which patients could benefit from thymosin α1 therapy were uncertain. STUDY DESIGN AND METHODS: Patients with COVID-19 from 19 designated hospitals between January...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qin, Xie, Jianfeng, Zheng, Ruiqiang, Li, Xuyan, Chen, Hui, Tong, Zhaohui, Du, Bin, Qiu, Haibo, Yang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604217/
https://www.ncbi.nlm.nih.gov/pubmed/33208294
http://dx.doi.org/10.1016/j.intimp.2020.107143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604217/
https://www.ncbi.nlm.nih.gov/pubmed/33208294
http://dx.doi.org/10.1016/j.intimp.2020.107143

Ejemplares similares